1-11 of 11
Vikram B Wali
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6333: Genomic, transcriptomic, and epigenetic profiling of triple-negative breast cancer cells after Navitoclax treatment

Michal Marczyk, Vignesh Gunasekharan, Jun Zhao, Rihao Qu, Xiaotong Li, Gauri A. Patwardhan, Vikram B. Wali, Abhishek K. Gupta, Manoj M. Pillai, Yuval Kluger, Christos Hatzis, Lajos Pusztai
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 6333.
DOI: https://doi.org/10.1158/1538-7445.AM2020-6333
Published: 15 August 2020
View article
Journal Articles

Abstract 2073: A systematic investigation of the effect of scheduling of targeted combination therapies on response and dynamics of relapse in triple negative breast cancer cells

Gauri A. Patwardhan, Vikram B. Wali, Lajos Pusztai, Christos Hatzis
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2073.
DOI: https://doi.org/10.1158/1538-7445.AM2017-2073
Published: 01 July 2017
View article
Journal Articles

Abstract 1141: Evaluation of GABRP as a novel therapeutic target in triple negative breast cancer

Vikram B. Wali, Gauri A. Patwardhan, Christos Hatzis, Lajos Pusztai
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1141.
DOI: https://doi.org/10.1158/1538-7445.AM2017-1141
Published: 01 July 2017
View article
Journal Articles

Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer

Vikram B. Wali, Casey G. Langdon, Matthew A. Held, James T. Platt, Gauri A. Patwardhan, Anton Safonov, Bilge Aktas, Lajos Pusztai, David F. Stern, Christos Hatzis
Journal: Cancer Research
Cancer Res (2017) 77 (2): 566–578.
DOI: https://doi.org/10.1158/0008-5472.CAN-16-1901
Published: 16 January 2017
View article
PDF
Includes: Supplementary data
Journal Articles

miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer

Brian D. Adams, Vikram B. Wali, Christopher J. Cheng, Sachi Inukai, Carmen J. Booth, Seema Agarwal, David L. Rimm, Balázs Győrffy, Libero Santarpia, Lajos Pusztai, W. Mark Saltzman, Frank J. Slack
Journal: Cancer Research
Cancer Res (2016) 76 (4): 927–939.
DOI: https://doi.org/10.1158/0008-5472.CAN-15-2321
Published: 14 February 2016
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract PD3-2: Broad exonic DNA diversity is associated with resistance to taxane-FAC chemotherapy in triple negative breast cancer

Tingting Jiang, Weiwei Shi, William F Symmans, Charles Li, James Platt, Rosanna Lau, Vikram B Wali, Richard Lifton, Lajos Pusztai, Christos Hatzis
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): PD3-2.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-PD3-2
Published: 01 May 2015
View article
Journal Articles

Abstract PD3-4: Reliability of whole exome sequencing for assessing intratumor heterogeneity from breast tumor biopsies

Weiwei Shi, Anees Chagpar, Tingting Jiang, Donald R Lannin, Brigid Killelea, Nina Horowitz, Raymond Lim, James Platt, Charlotte KY Ng, Vikram B Wali, Britta Weigelt, Jorge S Reis-Filho, Christos Hatzis, Lajos Pusztai
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): PD3-4.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-PD3-4
Published: 01 May 2015
View article
Journal Articles

Abstract 1401: Overexpression of HER4 isoforms in transgenic mice reveal isoform-specific role in mammary gland development and carcinogenesis.

Vikram B. Wali, Maureen Gilmore-Hebert, Klaus Elenius, David F. Stern
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1401.
DOI: https://doi.org/10.1158/1538-7445.AM2013-1401
Published: 15 April 2013
View article
Journal Articles

Abstract 5417: Suppression in mevalonate synthesis mediates the antiproliferative effects of combined statin and γ-tocotrienol treatment in mammary tumor cells

Vikram B. Wali, Sunitha V. Bachawal, Paul W. Sylvester
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5417.
DOI: https://doi.org/10.1158/1538-7445.AM10-5417
Published: 15 April 2010
View article
Journal Articles

Abstract 4458: Antiproliferative effects of γ-tocotrienol are mediated by suppression in the activation of Met tyrosine kinase receptors in neoplastic +SA mammary epithelial cells

Sunitha V. Bachawal, Vikram B. Wali, Paul W. Sylvester
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4458.
DOI: https://doi.org/10.1158/1538-7445.AM10-4458
Published: 15 April 2010
View article
Journal Articles

Antiproliferative effects of HMG-CoA reductase inhibitors (statins) are significantly enhanced when used in combination with γ-tocotrienol in neoplastic mammary epithelial cells in culture

Vikram B. Wali, Paul W. Sylvester
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 318.
Published: 15 April 2006
View article